BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10429238)

  • 1. Therapeutic peptides revisited.
    Latham PW
    Nat Biotechnol; 1999 Aug; 17(8):755-7. PubMed ID: 10429238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial drug discovery and development--SRI's 11th Annual Summit. Antibacterial trends and current research.
    Silver LL
    IDrugs; 2006 Jun; 9(6):394-7. PubMed ID: 16752305
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic peptides: technological advances driving peptides into development.
    Sato AK; Viswanathan M; Kent RB; Wood CR
    Curr Opin Biotechnol; 2006 Dec; 17(6):638-42. PubMed ID: 17049837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody conjugates and therapeutic strategies.
    McCarron PA; Olwill SA; Marouf WM; Buick RJ; Walker B; Scott CJ
    Mol Interv; 2005 Dec; 5(6):368-80. PubMed ID: 16394252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetically based therapeutics for cancer: similarities and contrasts with traditional drug discovery and development.
    Hermiston TW; Kirn DH
    Mol Ther; 2005 Apr; 11(4):496-507. PubMed ID: 15771953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic advances in rheumatology with the use of recombinant proteins.
    Rothe A; Power BE; Hudson PJ
    Nat Clin Pract Rheumatol; 2008 Nov; 4(11):605-14. PubMed ID: 18813220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phage display-derived peptides as therapeutic alternatives to antibodies.
    Ladner RC; Sato AK; Gorzelany J; de Souza M
    Drug Discov Today; 2004 Jun; 9(12):525-9. PubMed ID: 15183160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The current state and future prospectives on the therapeutic administration of peptides and proteins of biotechnological origin].
    Mazza P
    Boll Chim Farm; 1991 Oct; 130(9):381-4. PubMed ID: 1799432
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of combinatorial and automated synthesis in drug discovery.
    Matthews IT
    Proc West Pharmacol Soc; 1997; 40():121-5. PubMed ID: 9436231
    [No Abstract]   [Full Text] [Related]  

  • 10. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies.
    Hancock RE; Sahl HG
    Nat Biotechnol; 2006 Dec; 24(12):1551-7. PubMed ID: 17160061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein drug stability: a formulation challenge.
    Frokjaer S; Otzen DE
    Nat Rev Drug Discov; 2005 Apr; 4(4):298-306. PubMed ID: 15803194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple sclerosis therapeutics: unexpected outcomes clouding undisputed successes.
    Wiendl H; Hohlfeld R
    Neurology; 2009 Mar; 72(11):1008-15. PubMed ID: 19289741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copolymer 1: an off-beat drug development story.
    Scheindlin S
    Mol Interv; 2004 Feb; 4(1):6-9. PubMed ID: 14993470
    [No Abstract]   [Full Text] [Related]  

  • 14. The emergence of peptides as therapeutic drugs for the inhibition of HIV-1.
    Huther A; Dietrich U
    AIDS Rev; 2007; 9(4):208-17. PubMed ID: 18219364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent developments in peptide-based cancer therapeutics.
    Sehgal A
    Curr Opin Drug Discov Devel; 2002 Mar; 5(2):245-50. PubMed ID: 11926130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug evaluation: tesamorelin, a synthetic human growth hormone releasing factor.
    Tomlinson B
    Curr Opin Investig Drugs; 2006 Oct; 7(10):936-45. PubMed ID: 17086939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific peptides for the therapeutic targeting of oncogenes.
    Privé GG; Melnick A
    Curr Opin Genet Dev; 2006 Feb; 16(1):71-7. PubMed ID: 16377176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Fourth International Peptide Symposium: discovery to drugs: the peptide pipeline.
    Benson H; Toth I
    Biopolymers; 2008; 90(5):588. PubMed ID: 18821571
    [No Abstract]   [Full Text] [Related]  

  • 20. The outlook for peptide drugs and the intricate relationship between the Active Pharmaceutical Ingredients manufacturer and their sponsors.
    de Chastonay J
    J Pept Sci; 2005 Nov; 11(11):754-5. PubMed ID: 16215959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.